Balchem Balance Sheet Health
Financial Health criteria checks 4/6
Balchem has a total shareholder equity of $1.1B and total debt of $309.6M, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are $1.6B and $543.2M respectively. Balchem's EBIT is $156.9M making its interest coverage ratio 6.9. It has cash and short-term investments of $64.4M.
Key information
29.4%
Debt to equity ratio
US$309.57m
Debt
Interest coverage ratio | 6.9x |
Cash | US$64.45m |
Equity | US$1.05b |
Total liabilities | US$543.23m |
Total assets | US$1.60b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BL9B's short term assets ($314.2M) exceed its short term liabilities ($148.5M).
Long Term Liabilities: BL9B's short term assets ($314.2M) do not cover its long term liabilities ($394.7M).
Debt to Equity History and Analysis
Debt Level: BL9B's net debt to equity ratio (23.3%) is considered satisfactory.
Reducing Debt: BL9B's debt to equity ratio has increased from 22.6% to 29.4% over the past 5 years.
Debt Coverage: BL9B's debt is well covered by operating cash flow (59.4%).
Interest Coverage: BL9B's interest payments on its debt are well covered by EBIT (6.9x coverage).